Centogene NV (CNTG)
0.378
0.00 (0.00%)
USD |
NASDAQ |
May 20, 13:15
Centogene Shareholders Equity (Quarterly): -27.95M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -27.95M |
| June 30, 2023 | -16.54M |
| June 30, 2022 | 22.05M |
| March 31, 2022 | 36.37M |
| December 31, 2021 | 30.64M |
| September 30, 2021 | 43.13M |
| June 30, 2021 | 67.75M |
| March 31, 2021 | 73.76M |
| Date | Value |
|---|---|
| December 31, 2020 | 79.74M |
| September 30, 2020 | 69.72M |
| June 30, 2020 | 46.71M |
| March 31, 2020 | 57.70M |
| December 31, 2019 | 67.05M |
| September 30, 2019 | 13.24M |
| June 30, 2019 | 18.58M |
| December 31, 2018 | 31.21M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-27.95M
Minimum
Dec 2023
79.74M
Maximum
Dec 2020
38.80M
Average
43.13M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| RadNet Inc | 872.96M |
| DermTech Inc | 57.18M |
| iSpecimen Inc | 6.813M |
| 23andMe Holding Co | 377.19M |
| Sera Prognostics Inc | 64.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.29M |
| Total Liabilities (Quarterly) | 113.23M |
| Debt to Equity Ratio | -2.601 |
| Current Ratio | 1.015 |
| Net Debt Paydown Yield | -48.56% |